[1]
D. A. M. Sharaf Eldeen and A. E. Abdelgawad, “Gemcitabine and vinorelbine: treatment option in recurrent platinum – resistant ovarian cancer”, Eur J Oncol Environ Health, vol. 22, no. 3-4, pp. 131–137, Mar. 2018.